RHOA and cerebral cavernous malformation: 2022; Riento and Ridley 2003). The CCM complex inhibits RhoA/ROCK signaling and mutations in CCM genes activate the RhoA–ROCK pathway, leading to the formation of CCM lesions (Richardson et al. 2013; Stockton et al., 2010).